277 related articles for article (PubMed ID: 28532298)
1. CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors.
Dcona MM; Morris BL; Ellis KC; Grossman SR
Cancer Biol Ther; 2017 Jun; 18(6):379-391. PubMed ID: 28532298
[TBL] [Abstract][Full Text] [Related]
2. Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities.
Dcona MM; Damle PK; Zarate-Perez F; Morris BL; Nawaz Z; Dennis MJ; Deng X; Korwar S; Singh SJ; Ellis KC; Royer WE; Bandyopadhyay D; Escalante C; Grossman SR
Mol Pharmacol; 2019 Jul; 96(1):99-108. PubMed ID: 31036695
[TBL] [Abstract][Full Text] [Related]
3. The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.
Blevins MA; Huang M; Zhao R
Mol Cancer Ther; 2017 Jun; 16(6):981-990. PubMed ID: 28576945
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP).
Korwar S; Morris BL; Parikh HI; Coover RA; Doughty TW; Love IM; Hilbert BJ; Royer WE; Kellogg GE; Grossman SR; Ellis KC
Bioorg Med Chem; 2016 Jun; 24(12):2707-15. PubMed ID: 27156192
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of C-terminal binding protein attenuates transcription factor 4 signaling to selectively target colon cancer stem cells.
Patel J; Baranwal S; Love IM; Patel NJ; Grossman SR; Patel BB
Cell Cycle; 2014; 13(22):3506-18. PubMed ID: 25483087
[TBL] [Abstract][Full Text] [Related]
6. Structure-guided design of a high affinity inhibitor to human CtBP.
Hilbert BJ; Morris BL; Ellis KC; Paulsen JL; Schiffer CA; Grossman SR; Royer WE
ACS Chem Biol; 2015 Apr; 10(4):1118-27. PubMed ID: 25636004
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of C-terminal binding protein in human cancer.
Straza MW; Paliwal S; Kovi RC; Rajeshkumar B; Trenh P; Parker D; Whalen GF; Lyle S; Schiffer CA; Grossman SR
Cell Cycle; 2010 Sep; 9(18):3740-50. PubMed ID: 20930544
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer.
Di LJ; Byun JS; Wong MM; Wakano C; Taylor T; Bilke S; Baek S; Hunter K; Yang H; Lee M; Zvosec C; Khramtsova G; Cheng F; Perou CM; Miller CR; Raab R; Olopade OI; Gardner K
Nat Commun; 2013; 4():1449. PubMed ID: 23385593
[TBL] [Abstract][Full Text] [Related]
9. Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasia.
Sumner ET; Chawla AT; Cororaton AD; Koblinski JE; Kovi RC; Love IM; Szomju BB; Korwar S; Ellis KC; Grossman SR
Oncogene; 2017 Aug; 36(33):4810-4816. PubMed ID: 28414304
[TBL] [Abstract][Full Text] [Related]
10. Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization.
Banerjee A; Birts CN; Darley M; Parker R; Mirnezami AH; West J; Cutress RI; Beers SA; Rose-Zerilli MJJ; Blaydes JP
Carcinogenesis; 2019 Jul; 40(7):871-882. PubMed ID: 30668646
[TBL] [Abstract][Full Text] [Related]
11. Small Molecule, NSC95397, Inhibits the CtBP1-Protein Partner Interaction and CtBP1-Mediated Transcriptional Repression.
Blevins MA; Kouznetsova J; Krueger AB; King R; Griner LM; Hu X; Southall N; Marugan JJ; Zhang Q; Ferrer M; Zhao R
J Biomol Screen; 2015 Jun; 20(5):663-72. PubMed ID: 25477201
[TBL] [Abstract][Full Text] [Related]
12. CtBP: A global regulator of balancing acts and homeostases.
Jaiswal A; Singh R
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188886. PubMed ID: 37001619
[TBL] [Abstract][Full Text] [Related]
13. MCRIP1, an ERK substrate, mediates ERK-induced gene silencing during epithelial-mesenchymal transition by regulating the co-repressor CtBP.
Ichikawa K; Kubota Y; Nakamura T; Weng JS; Tomida T; Saito H; Takekawa M
Mol Cell; 2015 Apr; 58(1):35-46. PubMed ID: 25728771
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation by C-terminal binding proteins.
Chinnadurai G
Int J Biochem Cell Biol; 2007; 39(9):1593-607. PubMed ID: 17336131
[TBL] [Abstract][Full Text] [Related]
15. CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4.
Wang L; Zhou H; Wang Y; Cui G; Di LJ
Cell Death Dis; 2015 Jan; 6(1):e1620. PubMed ID: 25633289
[TBL] [Abstract][Full Text] [Related]
16. The transcriptional corepressor CtBP: a foe of multiple tumor suppressors.
Chinnadurai G
Cancer Res; 2009 Feb; 69(3):731-4. PubMed ID: 19155295
[TBL] [Abstract][Full Text] [Related]
17. CPP-E1A fusion peptides inhibit CtBP-mediated transcriptional repression.
Blevins MA; Zhang C; Zhang L; Li H; Li X; Norris DA; Huang M; Zhao R
Mol Oncol; 2018 Aug; 12(8):1358-1373. PubMed ID: 29879296
[TBL] [Abstract][Full Text] [Related]
18. Cryo-EM structure of CtBP2 confirms tetrameric architecture.
Jecrois AM; Dcona MM; Deng X; Bandyopadhyay D; Grossman SR; Schiffer CA; Royer WE
Structure; 2021 Apr; 29(4):310-319.e5. PubMed ID: 33264605
[TBL] [Abstract][Full Text] [Related]
19. Conserved catalytic and C-terminal regulatory domains of the C-terminal binding protein corepressor fine-tune the transcriptional response in development.
Zhang YW; Arnosti DN
Mol Cell Biol; 2011 Jan; 31(2):375-84. PubMed ID: 21078873
[TBL] [Abstract][Full Text] [Related]
20. NADH/NAD
Erlandsen H; Jecrois AM; Nichols JC; Cole JL; Royer WE
FEBS Lett; 2022 Feb; 596(4):479-490. PubMed ID: 34997967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
